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Relative Hypovolaemia
Normovolaemia with ECF and ICF depletion
Plasma volume is frequently well maintained by oncotic forces
even in the presence of significant extracellular and intracel-
lular fluid losses. Intracellular fluid depletion develops rela-
tively slowly and can lead to significant total body fluid deple-
tion. Although not primarily hypovolaemia, induction of ana-
esthesia can markedly inhibit the protective reflexes that main-
tain ECF at the expense of the ICF and lead to rapid develop-
ment of hypovolaemia without any apparent volume loss. There
are a number of situations in which such intracellular volume
depletion can arise, including dehydration, fluid losses from
vomiting and diarrhoea, excessive sweating (particularly with
pyrexia) etc. Drug therapy, notably with diuretics or ACE in-
hibitors can also create this situation. Imbalance between the
ECF and ICF can occur as a result of alterations in the os-
motic state of the plasma.
Hyperosmolar states
Diabetes, particularly hyperosmolar non-ketotic states, fre-
quently leads to both extracellular and intracellular volume
depletion. Heat stroke will result primarily in intracellular fluid
depletion, as will hypernatraemia, with both conditions lead-
ing to a rise in the plasma sodium content, thus maintaining
plasma volume. Hypercalcaemia results in inhibition of so-
dium, water, calcium and magnesium reabsorption and can
result in severe extracellular and intracellular volume deple-
tion.
Use of hypertonic solutions
Hyperosmotic solutions, such as mannitol and hypertonic sa-
line can result in significant ECF and ICF depletion.
High output renal failure
The loss of renal tubular concentrating power in high output
renal failure will result in significant ECF and ICF depletion.
Capillary Leak
Aggressive resuscitation of patients with damaged capillary
endothelial integrity will result in overload of the extracellu-
lar fluid compartment, often with associated intravascular
volume depletion. Numerous conditions can lead to this situ-
ation including burns, major trauma and crush injuries; also
pro-inflammatory insults leading to third space losses such as
anaphylaxis, pancreatitis and septic shock. Excessive crystal-
loid administration in the presence of capillary leak can also






Relative hypovolaemia may be said to exist when there is an
imbalance between the intravascular fluid volume and the ca-
pacity of the vascular compartment or an imbalance between
the vascular space and the remainder of the extracellular fluid
(ECF) and intracellular fluid (ICF). There are four circum-
stances in which this kind of imbalance may exist:
- Hypovolaemia masked by vasoconstriction
- Normovolaemia with vasodilatation
- ECF and ICF volume depletion with maintained circulat-
ing blood volume
- Fluid overload with capillary leak
Hypovolaemia masked by vasoconstriction
Unrecognised hypovolaemia is extremely common in hospi-
tal patients and a major cause of morbidity and mortality.1;2
This is commonly encountered in early shock, accompanied
by vasoconstriction and splenic contraction, both of which
mask the relative volume depletion.
Similar imbalances of the relationship between plasma vol-
ume and vascular space can occur in the presence of exces-
sive quantities of vasoconstrictor substances, either through
iatrogenic administration or due to physiological catechola-
mine excess. Included in this latter group are conditions such
as phaeochromocytoma and autonomic dysfunction states as
seen in tetanus and chronic, high spinal cord injury. Patients
with pre-eclampsia are also likely to be plasma volume de-
pleted in the presence of elevated systemic vascular resistance.
On a chronic basis, hypertensive patients, especially those on
diuretic therapy are likely to have a relative volume deficiency.
Normovolaemia and vasodilatation
Autonomic dysfunction and spinal shock can also result ex-
cessive vasodilatation in the presence of a normal plasma vol-
ume resulting in relative hypovolaemia. Septic shock and ana-
phylaxis have the added dimension of capillary leak to com-
plicate the situation, leading to both inadequate plasma vol-
ume and vasodilatation.
Iatrogenic causes of excessive vasodilatation include re-
gional anaesthesia, with high spinal or epidural blockade and
the excessive use of vasodilator drugs.
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Consequences
Although the consequences of relative hypovolaemia will be
at least in part dependent on the underlying pathology, the sys-
temic results of inadequate organ perfusion constitute a medi-
cal emergency as any degree of hypovolaemia decreases tis-
sue oxygen delivery and may contribute to tissue hypoxia.
Renal dysfunction is a major risk and, in susceptible patients
there is an increased risk of myocardial ischaemia.
Clinical Picture
Hypovolaemia may be difficult to recognise, and is associ-
ated with a variety of clinical consequences, dependent on the
underlying pathology.
Vasoconstriction
Patients with excessive vasoconstriction maybe normotensive
or even hypertensive, and, particularly in the presence of ex-
cessive quantities of noradrenaline, may have bradycardia, al-
though tachycardia is more common.
Decreased organ perfusion is usually present, frequently af-
fecting renal function and may give the clinical picture of pre-
renal kidney dysfunction. Excessive vasoconstriction will re-
sult in increased cardiac work and possibly myocardial is-
chaemia. CVP (central venous pressure) maybe normal or even
raised and there will be inadequate perfusion with global tis-
sue ischaemia.
Vasodilatation
Almost invariably, patients with relative hypovolaemia due to
excessive vasodilatation will be hypotensive and may have
warm peripheries. Tachycardia is common and the CVP is usu-
ally low to very low
ECF Depletion
Loss of extracellular fluid is particularly difficult to assess.
Hypovolaemia usually appears only after vasodilatation, and
is thus frequently seen following induction of anaesthesia, the
establishment of a regional block or the administration of va-
sodilator drugs.
If the fluid loss is severe patients may show signs of dehy-
dration such as skin laxity and dry mucous membranes. CVP
is usually normal but urine output is low and the urine con-
centrated. Biochemical investigation may show signs of pre-
renal dysfunction, with a disproportionately elevated urea rela-
tive to the creatinine concentration. Urinary sodium is low or
very low unless renal function has been impaired.
Capillary Leak
In patients with capillary leak syndromes, oedema may be
marked, and the patients are usually hypotensive. CVP is vari-
able and unreliable as a measure of volume status. Crystalloid
therapy is generally ineffective in raising blood pressure and
colloids may be necessary. Urine output is low and the urine
concentrated as in ECF depletion. This form of hypovolaemia
will frequently have an obvious cause.
Assessment of Relative Hypovolaemia
The detection of relative hypovolaemia may be difficult, and
is the subject of considerable controversy. Hypovolaemia is
often occult and the traditional haemodynamic measures of
filling pressures, cardiac output and urine output may be mis-
leading2-6, and are poor indicators of central blood volume.
Clinicians frequently rely on surrogate variables such as car-
diac filling pressures, although these are known to be of lim-
ited value4 and as long ago as 1984 the statement was made
that “the commonly monitored variables, in and of themselves,
do not reflect adequately the blood volume status in critically
ill patients”.7 Nevertheless, many clinicians continue to rely
on simple numerical values of filling pressures as a guide to
volume therapy. Biochemical indicators of volume status are
also often misleading. Plasma osmolality may be useful, par-
ticularly if considered together with measures of urine vol-
ume and composition.
Numerous alternative approaches to the assessment of
plasma volume status have been suggested. These approaches
include direct measurements of blood and plasma volume us-
ing a variety of markers such as radio-labelled red cells, la-
belled albumin and exogenous indicators including
indocyanine green and fluorescent-labelled hydroxyethyl
starch.8-10 While such markers may provide improved detec-
tion of reductions in blood and plasma volume, they are rela-
tively limited in equating the adequacy of circulating volumes
to the total vascular space, and are not readily available as
clinical tools.
Other approaches to the problem of assessment of adequacy of
circulatory filling volume have relied on cardiovascular perfor-
mance indices, and thus attempted to derive the likely responsive-
ness of the circulation to volume therapy. Various aspects of sys-
tolic pressure variation as a marker of volume performance have
been advocated by numerous authors11-16, and, while this measure
seems to provide a reasonable guide to the fact that volume is defi-
cient, it does not, currently, provide a quantitative assessment. Fur-
thermore, the technique is not valuable in detecting volume over-
load. A variant of this technique, pulse pressure variation, has been
reported to give better results, and either technique was shown to
be superior to PAOP (pulmonary artery occlusion pressure) or CVP
measurement17 as a marker of patients likely to respond favourably
to fluid therapy. These techniques are limited to patients on posi-
tive pressure ventilation.15 Other approaches have included the use
of preload (CVP or pulmonary capillary wedge pressure) responses
to fluid challenges18;19, although these have only short-term reli-
ability4. Various methods to determine intra-thoracic blood vol-
ume4;20;21 have also been used with good correlation to cardiovas-
cular responses to fluid loading, but are not generally clinically
available. However, none of these is entirely reliable at present
and it is likely that alternative forms of assessment of this crucial
measure will be developed in the future.14
Incidence
Hypovolaemia is very common in hospital patients and is fre-
quently unrecognised.1 It has been estimated over many years
that relative hypovolaemia is present in 50% of ICU cases22;23
and that haemodynamic variables are of little use in its detec-
tion. Although the other techniques reviewed above may as-
sist in the diagnosis, no one finding in isolation is helpful and
the overall clinical picture of the patient must be considered.
Prediction of Hypovolaemia
A number of factors make the presence of hypovolaemia more
likely including the existence of demonstrable fluid losses,
negative fluid balance and evidence of poor peripheral perfu-
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tion with signs of absence of fluid overload including the ab-
sence of peripheral oedema, pulmonary oedema and CCF, a
scoring system has been proposed indicating the likelihood of
reduced central blood volume.23
Management
The approach to management of volume deficits largely de-
pends on the underlying pathology. The aim must be to re-
verse the pathological process if possible and to replace the
deficit with appropriate fluids.
Early shock
Here the objective must be to assess volume loss (likely to be in
the range of + 1500 ml) and to administer early, rapid fluid re-
placement. In this circumstance, crystalloid resuscitation should
be adequate unless there is ongoing loss. Subsequent volume
therapy should be based on an assessment of the estimated fluid
losses, and a global assessment of the patient’s haemodynamic
status, using all of the surrogate markers available to indicate the
requirements for volume therapy. Red cell infusions should be
administered against measured values of haematocrit with a trig-
ger level of 25% in otherwise healthy adults. Plasma products
(particularly fresh frozen plasma and cryoprecipitate) should be
reserved for the treatment of proven coagulation deficits. The
use of a mixture of crystalloid and colloid resuscitation fluids
appears rational, despite the lack of clear scientific evidence of
benefit from colloid infusions. There appears to be no place for
albumin in trauma resuscitation.
Excess Vasoconstriction
The presence of excessive vasoconstriction with hypertension
may be one of the most difficult diagnoses to make, and the
recognition of occult hypovolaemia may be very difficult, as
the patients may present with hypertension and pulmonary
oedema together with profound fluid deficits. The chest x-ray
from a patient suffering from a phaeochromocytoma crisis
(Figure 1) illustrates this point. As can be seen from the bio-
chemical data (Table 1), the patient was profoundly
hypovolaemic with pre-renal dysfunction. The use of diuret-
ics in such a patient will simply worsen the already deranged
organ perfusion and may, paradoxically, worsen the hyperten-
sion as the sympathetic nervous system attempts to correct
the increasing volume deficit. The key step is to treat hyper-
tension with appropriate vasodilator therapy. The traditional
agents, such as the nitrates and ACE inhibitors are both arteri-
olar and venular dilators and may lead to profound hypoten-
sion. Initial therapy with magnesium sulphate may be prefer-
able as it is a pure arteriolar dilator.24 Once hypertension has
been controlled, careful volume expansion can be undertaken,
and, in these circumstances, response of haemodynamic mea-
sures to fluid challenges may be very useful. Patients with
severely constricted central blood volume should be monitored
with serial measurements of haematocrit. In the patient whose
data are illustrated in the table, vasodilator therapy coupled
with careful fluid loading resulted in a strongly positive fluid
balance, with marked haemodilution, and simultaneous im-
provement in the cardiac failure (Table 1).
Capillary Leak
Capillary leak is common in ICU and the management strate-
gies depend on controlling the precipitating cause. Fluid
therapy choices may be critical, particularly in sepsis, and in-
appropriate fluid strategies may adversely affect outcome.
The mechanism of endothelial damage is multifactorial, in-
cluding the release of inflammatory mediators such as tumour
necrosis factor and Interleukins
1–6
, histamine and serotonin.
Leukocyte-endothelial cell interaction, with the activation of
adhesion molecules and inhibition of nitric oxide results in
capillary occlusion and worsening endothelial injury. This pro-
cess is further compounded by oxygen-derived free radicals
and the endothelial injury together with release of proteolytic
enzymes activates complement cascade, leading to DIC.
This capillary leak may be indicated by the presence of
micro-albuminuria, which correlates well with the time of onset
of the insult and is proportional to the magnitude of the injury
in many circumstances. Under normal conditions, the micro-
albuminuria resolves within hours, but if it persists, it is asso-
ciated with significantly worse outcome.25 There is extensive
animal evidence that volume therapy with hydroxyethyl starch
products may decrease the endothelial injury.26-32 However,
there is currently very limited evidence that this translates into
Figure 1. Chest x-ray of a patient with a phaeochromocytoma crisis: left
ventricular hypertrophy, left atrial hypertrophy and pulmonary oedema. Diu-
retic therapy was ineffective in resolving the pulmonary oedema, but vasodi-
lator treatment and volume expansion improved cardiac function sufficiently
to permit tumour excision, after which the patient made an uneventful and
complete recovery.
 Table 1. Biochemical data, on admission and after 4 days of vasodilator and
fluid therapy, for the patient whose chest x-ray is shown in Figure 1. Admis-
sion biochemistry shows clear evidence of pre-renal dysfunction. The post-
treatment data show marked haemodilution as evidenced by the drop in hae-
moglobin, with complete correction of renal function. At this stage the pa-
tient had a 4 litres positive fluid balance.
On Admission Post-treatment
Sodium 147 mmol/l 132 mmol/l
Potassium 3.0 mmol/l 3.9 mmol/l
Urea 20.6 mmol/l 5.9 mmol/l
Creatinine 193 mmol/l 77 mmol/l
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demonstrable benefit in human subjects, although some ad-
vantages for the starches compared with the gelatins have been
described.25;33-35
Early, Goal-directed Therapy
In sepsis, early establishment of aggressive volume therapy
together with cardiac support has been shown to improve out-
come, and this emphasises the importance of the early and
appropriate management of relative hypovolaemia.36 The na-
ture of the fluids best suited for resuscitation remains contro-
versial, and the crystalloid-colloid debate is still not settled.
As indicated above, there is good laboratory and some clini-
cal evidence that the hydroxyethyl starches may ameliorate
capillary leak, but currently there are no outcome studies that
demonstrate the superiority of any one fluid over another. The
recent SAFE study demonstrated only that small volume re-
suscitation with albumin resulted in similar outcomes to those
achieved with saline resuscitation in a general ICU popula-
tion, although there were suggestions that albumin may offer
advantages in sepsis and be potentially harmful in trauma.37
However, it should be noted that this study did not attempt to
measure blood volume, and there is good evidence that the
two groups were not equivalent in terms of resuscitation end-
points. Interpretations of the study should be limited to those
put forward by the authors themselves: i.e. that this study
showed that albumin, in the volumes administered, was not
dangerous.
Conclusions
Relative hypovolaemia is difficult to detect and a high index
of suspicion is required, particularly in critically ill patients,
if the adverse effects of hypovolaemia are to be avoided. The
management demands accurate, appropriate volume therapy
and aggressive management of the underlying pathology. The
lack of sound, objective measures of intravascular volume re-
quires that the entire clinical picture is considered when mak-
ing decisions about volume therapy.
References
1. Mythen M, Vercueil A: Fluid balance. Vox Sang. 2004; 87 Suppl1:
77-81
2. Jones JG, Wardrop CA: Measurement of blood volume in surgical
and intensive care practice. Br.J Anaesth 2000; 84: 226-35
3. Boussat S, Jacques T, Levy B, Laurent E, Gache A, Capellier G,
Neidhardt A: Intravascular volume monitoring and extravascular
lung water in septic patients with pulmonary edema. Intensive
Care Med 2002; 28: 712-8
4. Brock H, Gabriel C, Bibl D, Necek S: Monitoring intravascular vol-
umes for postoperative volume therapy. Eur.J Anaesthesiol. 2002;
19: 288-94
5. Dabrowski GP, Steinberg SM, Ferrara JJ, Flint LM: A critical as-
sessment of endpoints of shock resuscitation. Surg.Clin.North Am
2000; 80: 825-44
6. Junghans T, Bohm B, Haase O, Fritzmann J, Zuckermann-Becker
H: Conventional monitoring and intravascular volume measure-
ment can lead to different therapy after upper gastrointestinal tract
surgery. Intensive Care Med 2002; 28: 1273-5
7. Shippy CR, Appel PL, Shoemaker WC: Reliability of clinical moni-
toring to assess blood volume in critically ill patients. Crit Care
Med 1984; 12: 107-12
8. Mitra S, Chamney P, Greenwood R, Farrington K: Serial determi-
nations of absolute plasma volume with indocyanine green dur-
ing hemodialysis. J Am Soc Nephrol 2003; 14: 2345-51
9. Thomas E, Jones G, de Souza P, Wardrop C, Wusteman F: Mea-
suring blood volume with fluorescent-labeled hydroxyethyl starch.
Crit Care Med 2000; 28: 627-31
10. Tschaikowsky K, Neddermeyer U, Pscheidl E, von der EJ: Changes
in circulating blood volume after cardiac surgery measured by a
novel method using hydroxyethyl starch. Crit Care Med 2000; 28:
336-41
11. Beaussier M, Coriat P, Perel A, Lebret F, Kalfon P, Chemla D,
Lienhart A, Viars P: Determinants of systolic pressure variation in
patients venti lated after vascular surgery. J
Cardiothorac.Vasc.Anesth 1995; 9: 547-51
12. Berkenstadt H, Margalit N, Hadani M, Friedman Z, Segal E, Villa Y,
Perel A: Stroke volume variation as a predictor of fluid respon-
siveness in patients undergoing brain surgery. Anesth Analg 2001;
92: 984-9
13. Gunn SR, Pinsky MR: Implications of arterial pressure variation in
patients in the intensive care unit. Curr.Opin.Crit Care 2001; 7:
212-7
14. Pinsky MR: Hemodynamic monitoring in the intensive care unit.
Clin.Chest Med 2003; 24: 549-60
15. Preisman S, Pfeiffer U, Lieberman N, Perel A: New monitors of
intravascular volume: a comparison of arterial pressure waveform
analysis and the intrathoracic blood volume. Intensive Care Med
1997; 23: 651-7
16. Soncini M, Manfred G, Redaelli A, Attanasio A, Tosoni A, Venturino
M, Susini G: A computerized method to measure systolic pres-
sure variation (SPV) in mechanically ventilated patients. J
Clin.Monit.Comput. 2002; 17: 141-6
17. Kramer A, Zygun D, Hawes H, Easton P, Ferland A: Pulse pres-
sure variation predicts fluid responsiveness following coronary
artery bypass surgery. Chest 2004; 126: 1563-8
18. Weil MH, Shubin H: The "VIP" approach to the bedside manage-
ment of shock. JAMA 1969; 207: 337-40
19. Webb AR: Recognizing hypovolaemia. Minerva Anestesiol. 2001;
67: 185-9
20. Bendjelid K, Suter PM, Romand JA: The respiratory change in
preejection period: a new method to predict fluid responsiveness.
J Appl.Physiol 2004; 96: 337-42
21. Della RG, Costa MG: Hemodynamic-volumetric monitoring.
Minerva Anestesiol. 2004; 70: 229-32
22. Shoemaker WC, Monson DO: The effect of whole blood and
plasma expanders on volume-flow relationships in critically ill pa-
tients. Surg.Gynecol.Obstet. 1973; 137: 453-7
23. Stéphan F, Flahault A, Dieudonné N, Hollande J, Paillard F, Bonnet
F: Clinical evaluation of circulating blood volume in critically ill
patients - contribution of a clinical scoring system. Br.J.Anaesth.
2001; 86: 754-64
24. James MF, Cronje L: Pheochromocytoma crisis: the use of mag-
nesium sulfate. Anesth.Analg. 2004; 99: 680-6
25. Rittoo D, Gosling P, Burnley S, Bonnici C, Millns P, Simms MH,
Smith SRG, Vohra RK: The protective effect of hydroxyethyl starch
on pulmonary function in infra-renal aortic surgery is independent
of neutrophil elastase. Br.J.Anaesth. 2000; 84: 683-a
26. Axon RN, Baird MS, Lang JD, Brix AE, Nielsen VG: PentaLyte de-
creases lung injury after aort ic occlusion-reperfusion.
Am.J.Respir.Crit.Care Med. 1998; 157: 1982-90
27. Chi OZ, Lu X, Wei HM, Williams JA, Weiss HR: Hydroxyethyl starch
solution attenuates blood-brain barrier disruption caused by










































Southern African Journal of Anaesthesia & Analgesia - May 2005 72
Anesth.Analg. 1996; 83: 336-41
28. Collis RE, Collins PW, Gutteridge CN, Kaul A, Newland AC, Will-
iams DM, Webb AR: The effect of hydroxyethyl starch and other
plasma volume substitutes on endothelial cell activation; an in vitro
study. Intensive Care Med. 1994; 20: 37-41
29. Harms BA, Rosenfeld DJ, Pahl AC, Conhaim RL, Starling JR: Pul-
monary transvascular fluid filtration response to hypoproteinemia
and Hespan infusion. J.Surg.Res. 1990; 48: 408-14
30. Hofbauer R, Moser D, Hornykewycz S, Frass M, Kapiotis S:
Hydroxyethyl starch reduces the chemotaxis of white cells through
endothelial cell monolayers. Transfusion 1999; 39: 289-94
31. Wisselink W, Patetsios P, Panetta TF, Ramirez JA, Rodino W, Kirwin
JD, Zikria BA: Medium molecular weight pentastarch reduces
reperfusion injury by decreasing capillary leak in an animal model
of spinal cord ischemia. J.Vasc.Surg. 1998; 27: 109-16
32. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Schildberg FW,
Menger MD: Hydroxyethyl starch (130 kD), but not crystalloid vol-
ume support, improves microcirculation during normotensive
endotoxemia. Anesthesiology 2002; 97: 460-70
33. Allison KP, Gosling P, Jones S, Pallister I, Porter KM: Randomized
trial of hydroxyethyl starch versus gelatine for trauma resuscita-
tion. J Trauma 1999; 47: 1114-21
34. Rittoo D, Gosling P, Burnley S, Bonnici C, Millns P, Simms MH,
Smith SR, Vohra RK: Randomized study comparing the effects of
hydroxyethyl starch solution with Gelofusine on pulmonary func-
tion in patients undergoing abdominal aortic aneurysm surgery.
Br.J.Anaesth. 2004; 92: 61-6
35. Rittoo D, Gosling P, Bonnici C, Burnley S, Millns P, Simms MH,
Smith SR, Vohra RK: Splanchnic oxygenation in patients undergo-
ing abdominal aortic aneurysm repair and volume expansion with
eloHAES. Cardiovasc.Surg. 2002; 10: 128-33
36. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B,
Peterson E, Tomlanovich M: Early goal-directed therapy in the treat-
ment of severe sepsis and septic shock. N.Engl.J.Med. 2001; 345:
1368-77
37. The SAFE Study Investigators: A Comparison of Albumin and Sa-
line for Fluid Resuscitation in the Intensive Care Unit. N Engl J
Med 2004; 350: 2247-56.
D
ow
nl
oa
de
d 
by
 [
U
ni
ve
rs
ity
 o
f 
C
ap
e 
T
ow
n 
L
ib
ra
ri
es
] 
at
 2
3:
10
 0
4 
Ja
nu
ar
y 
20
16
 
